[PHARMA] QoQ Quarter Result on 30-Jun-2020 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- -55.45%
YoY- 7.52%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 793,499 634,583 624,804 645,763 819,921 715,683 716,849 7.00%
PBT 31,524 -13,506 4,093 14,326 30,880 -238,474 3,885 303.28%
Tax -8,696 6,459 -2,799 -4,719 -8,465 59,741 -3,509 83.02%
NP 22,828 -7,047 1,294 9,607 22,415 -178,733 376 1440.87%
-
NP to SH 23,136 -6,331 1,442 9,979 22,399 -178,598 481 1219.48%
-
Tax Rate 27.59% - 68.39% 32.94% 27.41% - 90.32% -
Total Cost 770,671 641,630 623,510 636,156 797,506 894,416 716,473 4.97%
-
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 10,468 2,614 3,920 6,530 15,673 - - -
Div Payout % 45.25% 0.00% 271.91% 65.45% 69.98% - - -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
NOSH 261,705 261,705 261,705 261,705 261,229 261,229 261,229 0.12%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 2.88% -1.11% 0.21% 1.49% 2.73% -24.97% 0.05% -
ROE 6.50% -1.88% 0.42% 2.79% 6.40% -53.06% 0.09% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 303.20 242.70 239.03 247.20 313.87 274.30 274.86 6.75%
EPS 8.84 -2.42 0.55 3.82 8.57 -68.45 0.18 1237.90%
DPS 4.00 1.00 1.50 2.50 6.00 0.00 0.00 -
NAPS 1.36 1.29 1.32 1.37 1.34 1.29 1.98 -22.13%
Adjusted Per Share Value based on latest NOSH - 261,705
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 55.06 44.03 43.35 44.81 56.89 49.66 49.74 7.00%
EPS 1.61 -0.44 0.10 0.69 1.55 -12.39 0.03 1319.33%
DPS 0.73 0.18 0.27 0.45 1.09 0.00 0.00 -
NAPS 0.247 0.234 0.2394 0.2483 0.2429 0.2335 0.3583 -21.94%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 3.26 5.00 4.32 2.22 1.26 2.06 2.44 -
P/RPS 1.08 2.06 1.81 0.90 0.40 0.75 0.89 13.75%
P/EPS 36.88 -206.50 783.09 58.12 14.69 -3.01 1,322.99 -90.78%
EY 2.71 -0.48 0.13 1.72 6.81 -33.23 0.08 944.69%
DY 1.23 0.20 0.35 1.13 4.76 0.00 0.00 -
P/NAPS 2.40 3.88 3.27 1.62 0.94 1.60 1.23 56.08%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 -
Price 4.03 3.49 5.72 4.42 1.88 2.04 2.21 -
P/RPS 1.33 1.44 2.39 1.79 0.60 0.74 0.80 40.29%
P/EPS 45.59 -144.14 1,036.87 115.71 21.93 -2.98 1,198.28 -88.66%
EY 2.19 -0.69 0.10 0.86 4.56 -33.55 0.08 806.48%
DY 0.99 0.29 0.26 0.57 3.19 0.00 0.00 -
P/NAPS 2.96 2.71 4.33 3.23 1.40 1.58 1.12 91.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment